Martins, ―The central role of the gut microbiota in chronic inflammatory diseases,‖

J. Immunol. Res., vol. 2014, p. 689492, 2014.

[90] Bruneau A, et al. Le microbiote intestinal : quels impacts sur la carcinogenèse et le traitement du cancer colorectal Bull Cancer (2017)

[91] Kristina B. Martinez , Vanessa Leone ,et Eugene B. Chang Régimes occidentaux, dysbiose intestinale et maladies métaboliques: sont-ils liés? 2017; 8 (2): 130-142 [92] C. M. Ferreira, A. T. Vieira, M. A. R. Vinolo, F. A. Oliveira, R. Curi, and F. dos

S. Martins, ―The central role of the gut microbiota in chronic inflammatory diseases,‖

J. Immunol. Res., vol. 2014, p. 68-94-92.

[93] C. P. Moran and F. Shanahan, ―Gut microbiota and obesity: role in aetiology and potential therapeutic target,‖ Best Pract. Res. Clin. Gastroenterol., vol. 28, no. 4, p. 585–597, Aug. 2014.

[94] Marie-Claire A.a, Leah T. Stiemsma, Nelly A, Eric M. Brown, Brett Fi. Le microbiome intestinal en début de vie: santé et maladien .2014.p 427

[95] J. E. Gern, ―Promising candidates for allergy prevention,‖ J. Allergy Clin. Immunol., vol.136, no. 1, p. 23–28, 2015.

100

[96] G. Fond, L. Boyer / Annales Me´dico-Psychologiques 177 (695–697696Microbiote et depression : une piste the´rapeutique prometteuse Microbiota and depression: A promising therapeutic avenue Guillaume Fond, Laurent Boyer Service d’information me´dicale, CEReSS, centre d’e´tude et de recherche sur les services de santé et la qualité de vie, faculté de médecine, Secteur Timone, EA 3279, Marseille université, AP–HM, 27, boulevard Jean-Moulin, 13005 Marseille, Francee 2019.

[97] Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, et al.Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand 2014;129:163–79.

[98] RE Ley , F. Bäckhed , P. Turnbaugh , CA Lozupone , RD Knight , JI Gordon

L'obésité modifie l'écologie microbienne

intestinaleProc. Natl. Acad. Sci. USA , 102 ( 2005 ) , pp. 11070 – 11075 CrossRefView Record dans ScopusGoogle Scholar

[99] Calum J. Walsh, Caitriona M. Guinane, Paul W. O’Toole, Paul D. Cotter, Beneficial modulation of the gut microbiota, FEBS Letters, Volume 588, Issue 22

[100] Sanders et al. Modification of normal flora by antibiotics : effects on individuals and the environment. New Dimensions in Antimicrobial Chemotherapy. 1984, p. 217–241. [101] Santosa et al. Probiotics and their potential health claims. Nutr Rev. 2006 ; 64:265-74.

[102] Parvez S. et al. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006 ; 100 : 1171-1185.

[103] Louis P, Flint HJ, Michel C. How to manipulate the microbiota : prebiotics. Adv Exp Med Biol. 2016 ; 902 : 119-42.

101

[104] Recommandations 2016 de l’ICNM (International Conference on Nutrition in Medicine) : http://www.pcrm.org/health/reports/seven-dietary-guidelines-healthy-microbiota

[105]

https://www.biocodexmicrobiotainstitute.com/pro/prise-en-charge-de-la-dysbioseWorld Gastroenterology Organisation Global Guidelines, ―Probiotics and prebiotics.‖2008.

[106] Fando ngamba ST. Isolation et caractérisation des lactobacilles dans les fèces de poules. [Yaounde]; 2012.

[107] Izquierdo Alegre E. Les protéines bactériennes en tant que biomarqueurs de l’activité probiotique. IPHC de Strasbourg ; 2009.

[108] Holzapfel WH, Haberer P, Snel J, Schillinger U. Overview of gut flora and probiotics. Int J FoodMicrobiol. mai 1998 ; 41:85-101.

[109] D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea : Meta-analysis. BMJ 2003 ; 324:1361.

[110] Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis : The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16:1461-7.

[111] McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006 ; 101:812-22.

[112] Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J Clin Gastroenterol 2006 ; 40:249-55.

[113] Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics : Randomised double blind placebo controlled trial. BMJ 2007; 335:80.

102

[114] Hogenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998; 27:702-10.

[115] Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea : A systematic review. CMAJ 2005;173:167-70. Erratum in : CMAJ 2005; 173:345.

[116] Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease : Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000;31:1012-7.

[117] McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5:97-105.

[118] Gionchetti P, Amadini C, Rizzello F, et al. Probiotics for the treatment of postoperative complications following intestinal surgery. Best Pract Res Clin Gastroenterol 2003;17:821-31.

[119] Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45:1462-4.

[120] Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease : A randomised controlled trial with Lactobacillus GG. Gut 2002; 51:405-9.

[121] Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22:56-63.

[122] Jones JL, Foxx-Orenstein AE. The role of probiotics in inflammatory bowel disease. Dig Dis Sci 2007;52: 607-11.

[123] Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21: 44-50.

103

[124] Pereg D, Kimhi O, Tirosh A, et al. The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. Am J Infect Control 2005;33:122-5.

[125] Whelan K. Enteral-tube-feeding diarrhoea : Manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc 2007;66:299-306.

[126] Camilleri M. Probiotics and irritable bowel syndrome : Rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006;40:264-9. [127] Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med

2005;257:78-92.

[128] G. Tarantino and C. Finelli, ―Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease,‖

Future Microbiol., vol. 10, p. 889–902, May 2015.

[129] J. E. Gern, ―Promising candidates for allergy prevention,‖ J. Allergy Clin. Immunol., vol.136, no. 1, p. 23–28, Jul. 2015.

[130] . M. Cox, S. Yamanishi, J. Sohn, A. V. Alekseyenko, J. M. Leung, I. Cho, S. G. Kim, H. Li, Z. Gao, D. Mahana, J. G. Zárate Rodriguez, A. B. Rogers, N. Robine, P. ng Loke, and M. J. Blaser, ―Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences,‖ Cell, vol. 158, no. 4, p. 705–721, Aug. 2014.

[131] World Gastroenterology Organisation Global Guidelines, ―Probiotics and prebiotics.‖ 2008.

[132] G. R. Gibson, H. M. Probert, J. V. Loo, R. A. Rastall, and M. B. Roberfroid, ―Dietary modulation of the human colonic microbiota: updating the concept of prebiotics,‖ Nutr. Res. Rev., vol. 17, no. 2, p. 259–275, Dec. 2004.

[133] affssa, ―Effects of probiotics and prebiotics on flora and immunity in adults.‖ février-

104

[134] B. T. S. Beserra, R. Fernandes, V. A. do Rosario, M. C. Mocellin, M. G. F. Kuntz, and E. B. S. M. Trindade, ―A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity,‖ Clin. Nutr. Edinb. Scotl., Oct. 2014

[135] N. Salazar, S. Arboleya, L. Valdés, C. Stanton, P. Ross, L. Ruiz, M. Gueimonde, and C. G. de Los Reyes-Gavilán, ―The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations,‖ Front. Genet., vol. 5, p. 406, 2014.

[136] K. Tsilingiri, T. Barbosa, G. Penna, F. Caprioli, A. Sonzogni, G. Viale, and M.Rescigno, ―Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model,‖ Gut, vol. 61, no. 7, p. 1007–1015, Jul. 2012.

[137] https://www.medecinesciences.org/en/articles/medsci/full_html/2016/11/medsci20163 211p991/medsci20163211p991.html#F1

[138] Zhang F, Luo W, Shi Y, et al. Should we standardize the 1,700-year-old fecal microbiota transplantation. Am J Gastroenterol 2012 ; 107 : 1755– 1756. [CrossRef] [Google Scholar]

[139] C. De Filippo , et al.Impact d'une alimentation sur la formation du microbiote intestinal révélé par une étude comparative chez des enfants d'Europe et d'Afrique rurale Proc. Natl. Acad. Sci. , 107 ( 2010 ) , pp. 14691 - 96

[140] K. Liszt , J. Zwielehner , M. Handschur , B. Hippe , R. Thaler , AG Haslberger Caractérisation des bactéries, clostridies et bactéroïdes dans les fèces des végétariens à l'aide des empreintes digitales qPCR et PCR-DGGE Ann. Nutr. Metab. , 54 ( 2009 ) , pp. 253 - 257

105

[141] BB Matijasic, T. Obermajer, L. Lipoglavsek, I. Grabnar, G. Avgustin, I. Rogelj Association du type alimentaire avec le microbiote fécal chez les végétariens et les omnivores en Slovénie EUR. J. Nutr. (2013 ) Google Scholar

[142] A. Cotillard, et al.Impact de l'intervention alimentaire sur la richesse des gènes microbiens intestinaux Nature , 500 ( 2013 ) , p. 585 – 588 CrossRefView Record dans ScopusGoogle Scholar

[143] GD Wu , et al.Relier les régimes alimentaires à long terme avec les ntérotypes microbiens intestinaux Sciences , 334 ( 2 011 ) , pp. 105 – 108 CrossRefView Record dans ScopusGoogle Scholar

[144] GT Macfarlane , S. MacfarlaneBactéries, fermentation colique et santé gastro-intestinale J. AOAC Int. , 95 2012 , p. 50 – 60

[145] G.R. Gibson, HM Probert , J. Van Loo , RA Rastall , MB Roberfroid , Modulation alimentaire du microbiote colique humain: mise à jour du concept des prébiotiques . Nutr. Res. Rev. , 17 , ( 2004 ), 259 - 275 .

[146] A. Costabile , S. Kolida , A. Klinder , E. Gietl , M. Bäuerlein , C. Frohberg , V. Landschütze , GR Gibson , Une étude croisée en double aveugle, contrôlée contre placebo, pour établir l'effet bifidogène d'une inuline à très longue chaîne extraite d'artichaut ( Cynara scolymus ) chez des sujets humains en bonne santé . Br. J. Nutr. , 104, (2010 ), 1007 –

[147] P.T. Koleva, RS Valcheva , X. Sun , MG Gänzle , LA Dieleman , l' inuline et les fructo-oligosaccharides ont des effets divergents sur la colite et le microbiote commensal chez les rats transgéniques HLAB27 . Br. J. Nutr. , 108 , ( 2012 ), 1633 1643 .

106

[148] P. Ramnani , E. Gaudier , M. Bingham , P. Van Bruggen , KM Tuohy , GR Gibson , Effet prébiotique des injections de fruits et légumes contenant de l'inuline d'artichaut de Jérusalem: une étude d'intervention humaine . Br. J. Nutr. , 104 , ( 2010 ), 233 - 240 .

[149] Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958 ; 44 : 854– 59. [PubMed] [Google Scholar]

[150] Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation : current clinical efficacy and future prospects. Clin Exp Gastroenterol 2015 ; 8 : 285– 291. [CrossRef] [PubMed] [Google Scholar].

[151] Dougé A, et al. Microbiote intestinal et allogreffe de cellulessouches hématopoïétiques. Bull Cancer (2019), https://doi.org/10.1016/j.bulcan.2019.08.014. [152] Batista R, et al. Le transfert de microbiote fécal lors d’infections récidivantes à

Clostridium difficile. Cadre et aspects pharmacotechniques. Ann Pharm Fr (2015),

http://dx.doi.org/10.1016/j.pharma.2015.02.004

[153] Gough E, Shaikh H, Manges AR, (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis ; 53 : 994-1002.